Reevaluation of hepatocarcinogenesis by HBV insertional mutagenesis
| Project/Area Number |
16590619
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Gastroenterology
|
|---|
| Research Institution | Osaka City University |
|---|
Principal Investigator |
TAMORI Akihiro Osaka City University, Graduate School of Medicine, Instructor, 大学院医学研究科, 講師 (30291595)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
NISHIGUCHI Shuhei Hyogo College of Medicine, Department of Internal Medicine, Professor, 大学院医学研究科, 教授 (10192246)
|
|---|
| Project Period (FY) |
2004 – 2006
|
| Project Status |
Completed (Fiscal Year 2006)
|
| Budget Amount *help |
¥3,000,000 (Direct Cost: ¥3,000,000)
Fiscal Year 2006: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 2005: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 2004: ¥1,200,000 (Direct Cost: ¥1,200,000)
|
|---|
| Keywords | Hepatocellular carcinoma / Heptitis B virus / insertion / human genome / gene expression / hepatocarcinogenesis |
|---|
| Research Abstract |
Integration of hepatitis B virus (HBV) DNA into the human genome is one of the most important steps in HBV-related carcinogenesis. We attempted to find the link between HBV DNA, the adjoining cellular sequence, and altered gene expression in hepatocellular carcinoma (HCC) with integrated HBV DNA. We examined 88 cases of HCC infected with HBV by cassette-ligation mediated PCR. The human DNA adjacent to the integrated HBV DNA was sequenced. Protein-coding sequences were searched for in the human sequence. In five cases with HBV DNA integration, from which good quality RNA was extracted, gene expression was examined by cDNA microarray analysis.
The human DNA sequence successive to integrated HBV DNA was determined in the 15 HCCs. Eight protein-coding regions were involved: ras responsive element binding protein 1, Calmodulinl, Mixed Lineage Leukemia (MLL) 2, FLJ333655, LOC220272, LOC255345, LOC220220, and LOC168991. The MLL2 gene was expressed in three cases with HBV DNA integrated into exon 3 of MLL 2 and in one case with HBV DNA integrated into intron 3 of MLL2. Gene expression analysis suggested that two HCCs with HBV integrated into MLL2 had similar patterns of gene expression, as compared with three HCCs with HBV integrated into other loci of human chromosomes.
HBV DNA was integrated at random sites of human DNA, and the MLL2 gene was one of the targets for integration. Our results suggest that HBV DNA might modulate human genes near integration sites, followed by integration-site-specific expression of such genes during hepatocarcinogenesis.
|
Report
(4 results)
Research Products
(31 results)
